Outpost Medicine
Indianapolis
About Outpost Medicine
At Outpost, they are committed to developing novel therapeutics for the treatment of gastrointestinal and urologic disorders. The company's lead clinical-stage product candidate is in development for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $61.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2017)
- Website: outpostmedicine.com
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/outpost-medicine-29346 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.